Mixed tumors of the salivary glands and the skin (also known as chondroid syringomas) contain epithelial and myoepithelial components in a chondroid to myxoid stroma. Lesions that are composed solely of cells with myoepithelial differentiation are known as myoepitheliomas. These tumors have been well described in the salivary glands and many other sites, and within the past decade, cutaneous myoepitheliomas have been described as well. Immunohistochemically, these lesions are typically positive for S-100, cytokeratin and/or epithelial membrane antigen (EMA), with variable positivity for glial fibrillary acid protein and myogenic markers such as actin and calponin. Rare case reports have described the presence of melanocytes in mixed tumors of the salivary glands, but they have not been shown in mixed tumors or myoepitheliomas of the skin. We report a case of a cutaneous myoepithelioma with a distinct subpopulation of spindled to dendritic melanocytes, confirmed by immunohistochemical positivity for S-100, HMB-45 and melanoma antigen recognized by T-cells-1 (Mart-1).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1600-0560.2008.01105.x | DOI Listing |
Front Immunol
January 2025
Department of Radiation Oncology, Affiliated Hospital of Jiangnan University, Wuxi, China.
Background: Different doses of radiotherapy (RT) exert diverse effects on tumor immunity, although the precise irradiation method remains unknown. This study sought to elucidate the influence of combining different doses of RT with immune checkpoint inhibitors (ICIs) on the infiltration of CD8T cells within tumors, thereby augmenting the anti-tumor response.
Methods: Constructing a mouse model featuring bilateral lung cancer tumors subjected to high and low dose irradiation, the analysis of RNA transcriptome sequencing data and immunohistochemical validation for tumors exposed to various dosages guided the selection of the optimal low-dose irradiation scheme.
Urol Pract
December 2024
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Purpose: This retrospective study furthers our understanding of risk factors associated with hemorrhage and intervention in renal angiomyolipomas (R-AMLs), particularly in larger tumors (≥ 4 cm) and in childbearing-age (CBA; younger than 50 years) women. The objective was to refine risk stratification and optimize patient management.
Methods: Review of our institutional database identified patients with radiographic R-AML from 1997 to 2023.
Ear Nose Throat J
January 2025
Department of Neurosurgery, Christian Medical College, Vellore, TN, India.
Metastasizing pleomorphic adenoma is a rare entity that has the propensity for distant metastasis despite being histologically benign. We report the case of a 56-year-old woman with a long-standing right upper neck swelling and a recent-onset swelling over the left side of the scalp. Clinical workup did not reveal any other tumor deposits in the body.
View Article and Find Full Text PDFRadiol Case Rep
March 2025
Department of Radiology, University of California, Irvine, CA, USA.
Mixed epithelial and stromal tumor (MEST) of the kidney is a rare benign neoplasm composed of both stromal and epithelial components. MEST is mainly seen in adults with a strong predilection for perimenopausal women with history of hormone replacement therapy. While MEST is generally benign, there are reported cases of malignant transformation and adverse clinical outcomes.
View Article and Find Full Text PDFCureus
December 2024
Department of Diagnostic Pathology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, JPN.
Pleomorphic adenoma of the trachea is a rare benign tumor, often challenging to diagnose due to nonspecific symptoms. We report a case of a 72-year-old female with a 10-year history of presumed bronchial asthma, presenting with persistent dyspnea. Preoperative assessment for breast cancer surgery revealed severe obstructive ventilatory impairment.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!